SU1 COST-EFFECTIVENESS OF CYCLOOXYGENASE-2 INHIBITOR PARECOXIB COMPARED TO OPIOIDS AFTER NONCARDIAC SURGERY INTHE UNITED KINGDOM
Autor: | Remák, E, Muszbek, N, Manson, SC, Zlateva, G, Chen, C |
---|---|
Zdroj: | In Value in Health 2007 10(6):A230-A230 |
Databáze: | ScienceDirect |
Externí odkaz: |